387
Views
29
CrossRef citations to date
0
Altmetric
Connective tissue diseases

Prevalence and incidence of polymyositis and dermatomyositis in Japan

, , , &
Pages 477-480 | Received 08 May 2013, Accepted 18 Jun 2013, Published online: 21 Oct 2013

References

  • Oddis CV, Ascherman DP. Clinical features, classification, and epidemiology of inflammatory muscle disease. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th Ed. Philadelphia: Mosby/Elsevier; 2010. pp. 1439–40.
  • Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am. 2002;28(4):723–41.
  • Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis. 2010;13(2): 117–24.
  • Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc. 1969;44(9):649–93.
  • Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med. 1970;48(6):715–23.
  • Benbassat J, Geffel D, Zlotnick A. Epidemiology of polymyositis-dermatomyositis in Israel, 1960–76. Isr J Med Sci. 1980;16(3): 197–200.
  • Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol. 1990;17(10):1329–34.
  • Weitoft T. Occurrence of polymyositis in the county of Gävleborg, Sweden. Scand J Rheumatol. 1997;26(2):104–6.
  • Patrick M, Buchbinder R, Jolley D, Dennett X, Buchanan R. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol. 1999;26(5):1094–100.
  • Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993;52(12):857–61.
  • Kusumi M, Nakashima K, Nakayama H, Takahashi K. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci. 1995;49(3):169–74.
  • Araki S, Uchino M, Kumamoto T. Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan. Neuroepidemiology. 1987;6(3):120–9.
  • Tamakoshi A, Ohno Y, Sasaki R, Kubo N, Hashimoto S, Nakamura T, et al. Estimation of the number of patients with intractable diseases from a nationwide epidemiologic survey (in Japanese). Nihon Iji Shinpo. 1993;(3601);49–52.
  • Hayashi S, Umeda T. 35 years of Japanese policy on rare diseases. Lancet. 2008;372(9642):889–90.
  • Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22(4):668–74.
  • Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Report on Public Health Administration and Services 2003–2010 (in Japanese). Tokyo: Statistics and Information Department, Ministry of Health, Labour and Welfare, Japan. 2005–2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.